CIK: 0001400240 · Show all filings
Period: Q3 2017 (← Previous) (Next →)
Filing Date: Nov 3, 2017
Total Value ($000): $298,998 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | SERES THERAPEUTICS INC | 12,682,876 | $203,433 | 68.0% | $12.29 | — | COM | 81750R102 |
| — | SYROS PHARMACEUTICALS INC | 3,204,437 | $47,169 | 15.8% | $13.87 | — | COM | 87184Q107 |
| EDIT | EDITAS MEDICINE INC | 1,674,435 | $40,203 | 13.4% | $20.49 | -7.1% | COM | 28106W103 |
| — | T2 BIOSYSTEMS INC | 1,950,583 | $8,193 | 2.7% | $7.24 | — | COM | 89853L104 |